Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

NaNotics and Mayo Clinic to collaborate on nanomedicine cancer treatment

January 5, 2022 Research and Development

Nanomedical company NaNotics have announced a research collaboration with Mayo Clinic, to develop a NaNot that targets the soluble form …
News
fahczjixoai9a8z

NICE recommends PONVORY for the treatment of relapsing forms of multiple sclerosis

January 5, 2022 Research and Development

NICE has issued a positive Final Appraisal Document (FAD) recommending PONVORY® (ponesimod) as an option in England and Wales for …
News

Avacta lateral flow test receives CE mark for consumer self-testing

December 22, 2021 Research and Development

Avacta Group plc, a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® …
News

South African study suggests Omicron has a lower risk of hospitalisation than Delta

December 22, 2021 Research and Development

A new South African study suggests that there are reduced risks of hospitalisation and severe disease in people infected with …
News

FDA places clinical hold on use of injectable lenacapavir for HIV treatment

December 22, 2021 Research and Development

The FDA has placed a clinical hold on the use of injectable lenacapavir in borosilicate vials, in all ongoing clinical …
News
fgfwekgwyam8rvv

EMA recommends Nuvaxovid for authorisation, as WHO grants second Emergency Use Listing

December 22, 2021 Research and Development

Nuvaxovid™, the COVID-19 vaccine manufactured by the biotechnology company Novavax, has been listed for emergency use by WHO. The news …
News

Pfizer shares efficacy of COVID pill: near 90% protection against hospitalisation

December 15, 2021 Research and Development

Pfizer have announced that a final analysis of the antiviral pill Paxlovid (nirmatrelvir tablets and ritonavir tablets) shows 89% reduction …
News

Bionaut Labs and Candel Therapeutics collaborate to deliver immunotherapies

December 15, 2021 Research and Development

Bionaut Labs, and Candel Therapeutics, have announced a strategic collaboration to investigate the use of Bionaut’s remote-controlled microscale robots for …
News

Positive results in Phase III trial of candidemia and invasive candidiasis

December 15, 2021 Research and Development

Cidara Therapeutics and Mundipharma have announced positive topline data from the ReSTORE Phase III clinical trial, evaluating the efficacy and …
News

Sanofi and GSK announce positive booster data for COVID-19 vaccine candidate

December 15, 2021 Research and Development

Sanofi and GSK have announced positive preliminary booster data for their COVID-19 vaccine candidate, and continuation of their Phase III …
News
chris_hewitt_head_shot

Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director

December 13, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …
Appointment

Abbott receives CE mark for traumatic brain injury blood test

December 8, 2021 Research and Development

Abbott has received a CE mark for its laboratory traumatic brain injury (TBI) blood test. This will be the first …
News
mat-napo-pij34zrzeew-unsplash

Positive Phase III trial results for plant-based COVID-19 vaccine candidate

December 8, 2021 Research and Development

The biopharmaceutical company Medicago, alongside GlaxoSmithKline, have announced positive efficacy and safety results from the global Phase III placebo-controlled efficacy …
News

Booster vaccines may be needed for ‘years to come’, says Pfizer

December 8, 2021 Research and Development

Ben Osborn, country manager for Pfizer in the UK, has shared that coronavirus booster jabs will likely be necessary “for …
News

Omicron could become dominant variant in UK within weeks, expert warns

December 6, 2021 Research and Development

Infectious diseases expert, Professor Paul Hunter, has warned that Omicron could become the UK’s dominant COVID-19 variant within weeks.The UK …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026